ConductScience.org, home

Gene · 51592

Papers2,289

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Inflammatory myopathies with anti-TIF1γ antibodies and their association with neoplasms: a study of a series of 28 cases.Med Clin (Barc)202642413352PubTator, text miningPubMed
Lactate as a Chemical Modification on Proteins and Metabolites.Annu Rev Biochem202642331744PubTator, text miningPubMed
Chemo- and Immunotherapy in a Patient with Anti-TIF1γ-Positive Paraneoplastic Dermatomyositis in Adenocarcinoma of Unknown Primary Origin: A Challenging Path from Diagnosis to Treatment - A Case Report.
Case Rep Oncol202642325643PubTator, text miningPubMed
Dual regulation of metabolic reprogramming and protein competitive modifications: the core role and mechanism of MRPL36 in glioblastoma malignant progression.J Exp Clin Cancer Res202642316258PubTator, text miningPubMed
PKCα-mediated nuclear translocation of cGAS stabilizes β-catenin and drives metastasis.Mol Cell202642314650PubTator, text miningPubMed
Concordance for myositis-specific autoantibody detection between commercial ELISA and line blot assays: a multicentre study conducted across the Asia-Pacific region.Rheumatology (Oxford)202642302764PubTator, text miningPubMed
Prevalence and clinical correlates of infection in idiopathic inflammatory myopathies: A systematic review and meta-analysis of 14,548 patients.Autoimmun Rev202642208667PubTator, text miningPubMed
TIF1 Family Proteins as Modulators of Cell Death: Mechanisms and Therapeutic Opportunities.Biomolecules202642194066PubTator, text miningPubMed
OTUD5-TIF1γ-SMAD3/4 positive feedback loop inhibits TGF-β-induced EMT and metastasis in NSCLC.Cell Death Dis202642185242PubTator, text miningPubMed
Novel susceptible human leukocyte antigens allele in juvenile dermatomyositis: A study in Japanese patients.Pediatr Neonatol202642173749PubTator, text miningPubMed
More Than Skin Deep: Diffuse Calcinosis Mimicking Malignancy in Refractory Adult-Onset Dermatomyositis With Anti-transcription Intermediary Factor 1-Gamma (Anti-TIF1-γ) Positivity.Cureus202642147513PubTator, text miningPubMed
TRIM33 Reverses Cisplatin Resistance in Non-Small Cell Lung Cancer by Regulating the PI3K/AKT Pathway via Ubiquitination-Mediated Degradation of LPCAT1.World J Oncol202642147264PubTator, text miningPubMed
Comprehensive assessment of innovative immunoassays for the detection of myositis specific antibodies.Clin Chem Lab Med202642133817PubTator, text miningPubMed
Use of Baricitinib in Patients With TIF1-γ Positive Dermatomyositis Following a COVID-19 Infection.Exp Dermatol202642053148PubTator, text miningPubMed
Association between IL1B rs16944 polymorphism and the risk of idiopathic inflammatory myopathies.Front Immunol202641993189PubTator, text miningPubMed
Clinical characteristics and factors associated with dysphagia in idiopathic inflammatory myopathy: A cross-sectional observational study.Med Clin (Barc)202641946117PubTator, text miningPubMed
Real-world application of the international myositis assessment and clinical studies group guidelines on cancer risk stratification.Rheumatology (Oxford)202641936078PubTator, text miningPubMed
Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies.Sci Adv202641920990PubTator, text miningPubMed
Clinical and Autoantibody Profile of Inflammatory Myopathies in a Mexican Cohort: A Descriptive Study.J Clin Rheumatol202641894839PubTator, text miningPubMed
The Role of Ultrasound Pleural Irregularities in the Identification of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies.J Pers Med202641893030PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/51592/papers?page=2